Champions Oncology - End to End Pharmacology Solutions

End to End Pharmacology Solutions
Bridging the Gap Between Research and Clinic

Leverage a range of research and development solutions to improve the productivity of oncology drug development

Participate in the Champions Oncology PDX Indication Screen
for Lower cost, Large-scale PDX Pharmacology Studies

The CT26 HuSyngeneic Screen
ENROLLMENT EXTENDED THROUGH FEBRUARY 28th

Champions Oncology Workshop Series
March 4, 2020, Paris

Two Tracks - Utilizing PDX Models to Guide Clinical Trial Design or Immuno-Oncology 2.0: Latest Humanised Models for Preclinical Research

PDX Model Spotlight
EX20 EGFR Mutant Models

AACR 2019 Poster Presentation

AML PDX Platform to Evaluate Novel Therapeutic Agents

Our Latest Webinar

Clinical Flow Cytometry: Validation and Implementation in a Regulatory Setting

On-Demand Webinar Series

Learn more about humanized mouse models for the preclinical evaluation of novel immunotherapies

Access the Champions TumorGraft Database

Identify PDX cohorts based on molecular characteristics, patient treatment, standard-of-care testing outcomes, clinical features and more

Read Our Latest Newsletter

New Webinar!
Next Generation Humanzied Mice for AML and NK Cell Therapy Testing

Hematology
Oncology Models

The Children’s Cancer Therapy Development Institute is Collaborating with Champions Oncology and Jackson Laboratory to provide...

Champions Oncology and PhenoVista Biosciences Announce a Strategic Partnership to provide Oncology Imaging-Based Phenotypic Assays...